Experience

Framer Secures $100 Million Series D

August 28, 2025

Cooley advised Framer, a professional website design platform that has quickly become the platform of choice for companies that want to ship their entire .com, on its $100 million Series D financing.

Read more

Related contacts

Peter H. Werner
Partner in Charge – San Francisco, San Francisco
Daniel Shamah
Partner, New York
Tamim Bazzi
Partner, New York
Erin Wright
Associate, San Francisco
Karem M. Jarada
Associate, San Francisco
Christopher Kimball
Partner, Washington, DC
Bryan Berman
Special Counsel, Colorado
Sharon Connaughton
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
David Dalton
Associate, Santa Monica
Juan Nascimbene
Associate, London
David H. Zhou
Associate, Palo Alto
Kris Tsao Cachia
Paralegal Specialist, San Francisco
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

RPM Ventures Leads Firefly Aerospace’s Oversubscribed $175 Million Series D

November 12, 2024

Cooley advised early-stage venture capital firm RPM Ventures as the lead investor for Firefly Aerospace's oversubscribed $175 million Series D.

Read more

Related contacts

Kevin Rooney
Partner, San Francisco
Alison L. Tong
Associate, Seattle
Grant Schweikert
Special Counsel, Washington, DC
Alfred Browne
Partner, Boston
Parker Erkmann
Special Counsel, Washington, DC
Shelby Saunders
Associate, New York
David Fletcher
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
J.G. Harrington
Special Counsel, Washington, DC
Henry Wendel
Special Counsel, Washington, DC
Sarah Oliai
Associate, Washington, DC
Kris Tsao Cachia
Paralegal Specialist, San Francisco
Ron Metzger
Paralegal Specialist, San Francisco

Related Practices & Industries

Zymeworks – $115 Million Follow-On Offering

June 2, 2022

Cooley advised the underwriters on Zymeworks’ $115.0 million follow-on public offering of 11,035,000 common shares at a price to the public of $8.00 per share and pre-funded warrants to purchase 3,340,000 common shares at a price to the public of $7.9999 per pre-funded warrant. This includes 1,875,000 shares issued upon the exercise in full of the underwriters’ option to purchase additional shares. Zymeworks is a clinical-stage biopharmaceutical company developing and commercializing of next-generation multifunctional biotherapeutics. Partners Denny Won, Kristin VanderPas, Charlie Kim and Dave Peinsipp led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
David Peinsipp
Partner, San Francisco
Madison (JJ) Meng
Associate, San Francisco
Ron Metzger
Paralegal Specialist, San Francisco
Kris Tsao Cachia
Paralegal Specialist, San Francisco

Related Practices & Industries

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.